Commentary

A greener world by empowering data in ESG management and compliance.

Biologics are becoming an increasingly important treatment method for conditions such as cancer, autoimmune disorders and viral infections.

Even before the pandemic, Asian supply chains were already vulnerable to major disruptions: a surge in players and subcontractors, international trade disputes, natural disasters, and political upheavals. The pandemic has added even more risk and uncertainty, severely impacting production capacity and logistics routes, with goods manufactured in Asia particularly affected by stronger demand.